Pembrolizumab in Treating Participants With Leukoplakia

Clinical trial NCT03603223 · RECRUITING

Trial details

NCT number: NCT03603223
Sponsor: Jonsson Comprehensive Cancer Center
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Erythroleukoplakia Leukoplakia Verrucous Oral Leukoplakia

Start date: 2019-05-03
Primary completion: 2027-08-01
Enrollment: 26

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.